SINGAPORE (Nov 16): QT Vascular says it has reached a confidential settlement agreement with AngioScore, Inc on Tuesday.

In a Wednesday night filing, QT Vascular says the settlement "fully and finally resolve all past, present or future disputes" concerning pending or previously litigated matters between QT Vascular and the angioplasty company.

In April 2015, QT Vascular announced AngioScore had on June 29, 2012 initiated patent infringement proceedings against the company's subsidiaries, TriReme Medical, Quattro Vascular and the company's CEO, Dr Eitan Konstantino relating to the Chocolate PTA.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook